127 results

• FDA To Remove Suicide Risks From GLP-1 Side Effects Warnings

  January 15, 2026

  Irvin Jackson

  Federal regulators are asking manufacturers of GLP-1 weight loss drugs like Wegovy and Zepbound to remove warning labels linking the medications to increased suicide risks, saying they found no proof such risks exist.

• Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference

  January 13, 2026

  Irvin Jackson

  Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13.

• Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026

  December 23, 2025

  Irvin Jackson

  A federal judge has scheduled a series of deadlines designed to eliminate issues preventing GLP-1 lawsuits from moving forward with bellwether trials.

• Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL

  December 18, 2025

  Irvin Jackson

  All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications.

• Ozempic, Mounjaro Side Effects May Increase Risk of Cough: Study

  December 3, 2025

  Irvin Jackson

  A new study warns that drugs like Ozempic and Mounjaro carry a higher risk of chronic cough than most other diabetes drugs.

• Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects

  November 26, 2025

  Russell Maas

  An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.

• Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study

  November 21, 2025

  Irvin Jackson

  Harvard researchers warn that GLP-1 medications like Ozempic and Mounjaro carry a higher risk of gastrointestinal problems than diabetes drugs like Invokana and Januvia.

• Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court

  November 17, 2025

  Irvin Jackson

  Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries.

• Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues

  October 28, 2025

  Irvin Jackson

  Plaintiffs and defendants involved in GLP-1 stomach paralysis lawsuits are being given more time to prepare arguments over whether the cases are preempted by federal law and if there is evidence that can prove the drugs cause gastroparesis injuries.

• Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges

  October 21, 2025

  Irvin Jackson

  A lawsuit claims that a man’s Ozempic gastroparesis side effects have continued a year and a half after he stopped using the diabetes medication.